Healthy Living

Researchers Discover Key Molecule to Improve Cystic Fibrosis Treatment

How does it work?

Further research done by the team tested, in vitro, how a quorum-sensing inhibitor taken from the furanone family would alter the results. Brocherio says, "we showed that this molecule, by reducing the bacterial production of harmful residues, maintains treatment efficacy in the cells of patients with cystic fibrosis."